Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis

L Li, R He, H Yan, Z Leng, S Zhu, Z Gu - Nano Today, 2022 - Elsevier
As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance

Z Hammoud, N Khreich, L Auezova… - International journal of …, 2019 - Elsevier
Cyclodextrins (CDs) are cyclic oligosaccharides able to improve drug water solubility and
stability by forming CD/drug inclusion complexes. To further increase drug entrapment and …

Enhanced solubility and bioavailability of simvastatin by mechanochemically obtained complexes

R Kong, X Zhu, ES Meteleva, YS Chistyachenko… - International journal of …, 2017 - Elsevier
In the present work, complexes of simvastatin (SIM) with polysaccharide arabinogalactan
(AG) or disodium salt of glycyrrhizin acid (Na 2 GA) have been prepared using …

Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex

SK Shukla, A Chan, V Parvathaneni… - Journal of Molecular …, 2020 - Elsevier
Celastrol (Cela), a pentacyclic triterpenoid, has been explored widely due to its broad
therapeutic activity such as antioxidant, chemotherapeutic, neuroprotective etc. However …

Active intestinal drug absorption and the solubility-permeability interplay

D Porat, A Dahan - International journal of pharmaceutics, 2018 - Elsevier
The solubility-permeability interplay deals with the question: what is the concomitant effect
on the drug's apparent permeability when increasing the apparent solubility with a solubility …

Increasing cellular uptake and permeation of curcumin using a novel polymer-surfactant formulation

Z Liu, AB Lansley, TN Duong, JD Smart, AS Pannala - Biomolecules, 2022 - mdpi.com
Several therapeutically active molecules are poorly water-soluble, thereby creating a
challenge for pharmaceutical scientists to develop an active solution for their oral drug …

Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics

RP Dash, RJ Babu, NR Srinivas - Clinical pharmacokinetics, 2018 - Springer
The recent approval of edaravone has provided an intravenous option to treat amyotrophic
lateral sclerosis (ALS) in addition to the existing oral agent, riluzole. The present work was …

Predicting Solubility of Newly-Approved Drugs (2016–2020) with a Simple ABSOLV and GSE(Flexible-Acceptor) Consensus Model Outperforming Random Forest …

A Avdeef, M Kansy - Journal of Solution Chemistry, 2022 - Springer
This study applies the 'Flexible-Acceptor'variant of the General Solubility Equation, GSE (Φ,
B), to the prediction of the aqueous intrinsic solubility, log10 S 0, of FDA recently-approved …

Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability

B Vaidya, SK Shukla, S Kolluru, M Huen, N Mulla… - Carbohydrate …, 2019 - Elsevier
Cyclodextrin complex of nintedanib was prepared aiming for increased bio-activity and
improved transport across intestinal membrane with reduced p-glycoprotein (p-gp) efflux …

Solubility and dissolution enhancement of dexibuprofen with hydroxypropylbetacyclodextrin (HPβCD) and poloxamers (188/407) inclusion complexes: preparation …

R Munir, A Hadi, SD Khan, S Asghar, M Irfan, IU Khan… - Polymers, 2022 - mdpi.com
The objective of this study was to improve the dissolution and solubility of dexibuprofen
(DEX) using hydroxypropyl beta cyclodextrin (HPβCD) inclusion complexes and also to …